Safety and efficacy of first microRNA for CVD in humans confirmed

Safety and efficacy of first microRNA for CVD in humans confirmed

A research group from Goethe University and University Hospital Frankfurt was able to show that an inhibitor against microRNA-92a is effective in humans. The clinical study was supported by the German Center for Cardiovascular Research (DZHK). The microRNA therapy...